Michael Specka
Impact in
- Toxicology top 5%
- Forensic Toxicology and Drug Analysis
- Psychiatry and Mental health top 10%
- Attention Deficit Hyperactivity Disorder
Papers in
-
- Bipolar Disorder and Treatment 5
- Attention Deficit Hyperactivity Disorder 5
- Schizophrenia research and treatment 4
-
- Child and Adolescent Psychosocial and Emotional Development 4
- Co-authors
- Norbert Scherbaum (62 shared papers)Udo Bonnet (29 shared papers)Markus Gastpar (11 shared papers)Thomas Finkbeiner (4 shared papers)Eugen Davids (7 shared papers)Fabrizio Schifano (12 shared papers)Peter W. Nyhuis (6 shared papers)Markus Banger (5 shared papers)
- Journals
- Frontiers in Psychiatry (7 papers)Progress in Neuro-Psychopharmacology and Biological Psychiatry (6 papers)Pharmacopsychiatry (4 papers)Substance Use & Misuse (3 papers)Journal of Psychoactive Drugs (3 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Michael Specka
63 papers receiving 689 citations
Peers
Comparison fields: 5 of 80
- Toxicology 56
- Psychiatry and Mental health 119
- Neurology 99
- Pharmacology 105
- Epidemiology 149
Countries citing papers authored by Michael Specka
This map shows the geographic impact of Michael Specka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Specka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Specka more than expected).
Fields of papers citing papers by Michael Specka
This network shows the impact of papers produced by Michael Specka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Specka. The network helps show where Michael Specka may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Specka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 81 | |
| 2 | 2003 | 56 | |
| 3 | 2008 | 55 | |
| 4 | 2020 | 35 | |
| 5 | 2005 | 35 | |
| 6 | 2009 | 35 | |
| 7 | 2005 | 27 | |
| 8 | 2011 | 26 | |
| 9 | 2021 | 24 | |
| 10 | 2011 | 23 | |
| 11 | 2014 | 20 | |
| 12 | 2010 | 19 | |
| 13 | 2006 | 18 | |
| 14 | 2016 | 18 | |
| 15 | 2006 | 16 | |
| 16 | 2006 | 15 | |
| 17 | 2007 | 14 | |
| 18 | 2002 | 14 | |
| 19 | 2022 | 13 | |
| 20 | 2015 | 13 |
About Michael Specka
Michael Specka is a scholar working on Psychiatry and Mental health, Clinical Psychology, Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology, having authored 71 papers that have together received 735 indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (12 papers), Substance Abuse Treatment and Outcomes (10 papers), Cannabis and Cannabinoid Research (9 papers), Bipolar Disorder and Treatment (5 papers), Alcoholism and Thiamine Deficiency (5 papers), Attention Deficit Hyperactivity Disorder (5 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers) and Schizophrenia research and treatment (4 papers). The work is most often cited by research in Toxicology (56 citations), Psychiatry and Mental health (119 citations), Neurology (99 citations), Pharmacology (105 citations) and Epidemiology (149 citations). Michael Specka has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Norbert Scherbaum, Udo Bonnet, Markus Gastpar, Thomas Finkbeiner, Eugen Davids, Fabrizio Schifano, Peter W. Nyhuis, Markus Banger, F. Markus Leweke and Thomas Kuhlmann. Their work appears in journals such as Frontiers in Psychiatry, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Pharmacopsychiatry, Substance Use & Misuse and Journal of Psychoactive Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.